Chen, D.D., Dong, Y.G., Liu, D. and He, J.G. (2009) Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals. Clinical and Experimental Pharmacology and Physiology, 36, 925-932. doi:10.1111/j.1440-1681.2009.05173.x

has been cited by the following article:

• TITLE: Cardioprotective effects of tea and its catechins

  AUTHORS: Nana Li, Yue Zhao, Yuerong Liang

  KEYWORDS: Camellia sinensis; Hypertension; Antioxidant; Metabolic Syndrome; Endothelial Dysfunction; Cardiac Hypertrophy; Mitochondria

  JOURNAL NAME: Health, Vol.5 No.4A, April 18, 2013

  ABSTRACT: Tea is rich in polyphenolic catechins which are beneficial to health. There have been evidences suggesting that habitual tea consumption may reduce the risk of cardiovascular disease (CVD). Intake of tea or catechins isolated from tea was shown to inhibit the development of CVD in population studies and in animal models. Many possible pathways and mechanisms were investigated. There have been evidences showing that tea and tea catechins reduced the risk of CVD by enhancing antioxidant activity, attenuating metabolic syndrome, inhibiting angiotensin converting enzyme, improving endothelial dys-function, preventing cardiac hypertrophy and protecting mitochondria from damage.